The Effects of Momordica charantia on Type 2 Diabetes Mellitus and Alzheimer's Disease

E Richter, T Geetha, D Burnett, TL Broderick… - International Journal of …, 2023 - mdpi.com
T2DM is a complex metabolic disorder characterized by hyperglycemia and glucose
intolerance. It is recognized as one of the most common metabolic disorders and its …

Beneficial effect and mechanism of action of Momordica charantia in the treatment of diabetes mellitus: a mini review

C Garau, E Cummings, DA Phoenix… - International Journal of …, 2003 - karger.com
Diabetes mellitus (DM) is the most common of the endocrine disorders and represents a
global health problem. DM is characterized by chronic hyperglycaemia due to relative or …

[HTML][HTML] Suppl 2: Medicinal chemistry of the anti-diabetic effects of Momordica charantia: active constituents and modes of actions

J Singh, E Cumming, G Manoharan… - The open medicinal …, 2011 - ncbi.nlm.nih.gov
Diabetes mellitus (DM) is one of the oldest known human disease currently affecting more
than 200 million people worldwide. Diabetes mellitus is derived from two Greek words …

Bioactives of Momordica charantia as Potential Anti-Diabetic/Hypoglycemic Agents

B Xu, Z Li, T Zeng, J Zhan, S Wang, CT Ho, S Li - Molecules, 2022 - mdpi.com
Momordica charantia L., a member of the Curcubitaceae family, has traditionally been used
as herbal medicine and as a vegetable. Functional ingredients of M. charantia play …

Recent Advances in Momordica charantia: Functional Components and Biological Activities

S Jia, M Shen, F Zhang, J Xie - International journal of molecular sciences, 2017 - mdpi.com
Momordica charantia L.(M. charantia), a member of the Cucurbitaceae family, is widely
distributed in tropical and subtropical regions of the world. It has been used in folk medicine …

A detailed review on the phytochemical profiles and anti-diabetic mechanisms of Momordica charantia

SF Oyelere, OH Ajayi, TE Ayoade, GBS Pereira… - Heliyon, 2022 - cell.com
Diabetes mellitus is the most well-known endocrine dilemma suffered by hundreds of million
people globally, with an annual mortality of more than one million people. This high mortality …

Momordica charantia, a Nutraceutical Approach for Inflammatory Related Diseases

M Bortolotti, D Mercatelli, L Polito - Frontiers in pharmacology, 2019 - frontiersin.org
Momordica charantia, commonly called bitter melon, is a plant belonging to Cucurbitaceae
family known for centuries for its pharmacological activities, and nutritional properties. Due …

Potential use of bitter melon (Momordica charantia) derived compounds as antidiabetics: in silico and in vivo studies

OO Elekofehinti, EO Ariyo, MO Akinjiyan, OS Olayeriju… - Pathophysiology, 2018 - Elsevier
Momordica charantia (bitter lemon) belongs to the cucurbitaceae family which has been
extensively used in traditional medicines for the cure of various ailments such as cancer and …

Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potency

B Joseph, D Jini - Asian pacific journal of tropical disease, 2013 - Elsevier
Diabetes mellitus is among the most common disorder in developed and developing
countries, and the disease is increasing rapidly in most parts of the world. It has been …

Charantin: An important lead compound from Momordica charantia for the treatment of diabetes

S Desai, P Tatke - Journal of Pharmacognosy and Phytochemistry, 2015 - phytojournal.com
The development of effective and safe anti-diabetic agent is still a major challenge for
modern scientific research. Traditionally fruit juice of Momordica charantia has been used for …